Eisai is to enter the Russian market for the first time with the launch of epilepsy drug Zonegran. Entry into the …
Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …
Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic …

